Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy

Vox Sanguinis

Volumn 89, Issue 2, 2005, Pages 63-70

  Brown, Paul ^a  

^a NONE   (United States)

Author keywords

Blood screening tests; Creutzfeldt Jakob disease; Prion; Prion protein; Scrapie; Transmissible spongiform encephalopathy

Indexed keywords

PRION PROTEIN;

CAPILLARY ELECTROPHORESIS; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; RELIABILITY; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; VALIDATION PROCESS;

AGED; ANIMALS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; MALE; MASS SCREENING; PRION DISEASES; PRIONS; PROTEIN FOLDING; SCRAPIE;

EID: 23844471279     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00683.x     Document Type: Review

References (26)

1. Brown P: Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol 1995; 2:472-477
2. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F: Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83:2897-2905
3. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-421
4. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW: Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:529-531
5. Brown P, Cervenakova L, Diringer H: Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 2001; 137:5-13
6. Brown P, Preece M, Brandel J-P, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman N, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the Millennium. Neurology 2000;55:1075-1081
7. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW: Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-739
8. Foster PR, Welsch AG, McLean C, Griffin BD, Hardy JC, Bartley A, MacDonald S, Bailey AC: Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products. Vox Sang 2000; 78:86-95
9. Stenland CJ, Lee DC, Brown P, Petteway SR Jr, Rubenstein R: Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma. Transfusion 2002; 42:1497-1500
10. Sowemimo-Coker S, Kascsak R, Kim A, Andrade F, Pesci A, Kascsak R, Meeker C, Carp R, Brown P: Removal of exogenous (spiked) and endogenous prion infectivity from red cell concentrates using a new prototype of leukocyte reduction filter. Transfusion 2005, in press
11. Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC: Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun 1983; 41:154-161
12. Vey M, Baron H, Weimer T, Gröner A: Purity of spiking agent affects partitioning of prions in plasma protein purification. Biologicals 2002; 30:187-196
13. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN: The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998; 38:810-816
14. Lee DC, Stenland CJ, Miller JL, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, Rubenstein R, Fournel M, Petteway SR Jr: A direct relationship between partitioning of the pathogenic priori protein and transmissible spongiform encephalopathy infectivity during purification of plasma proteins. Transfusion 2001; 41:449-455
15. Klöhn PC, Stolze L, Enari M, Weissmann C: A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 2003; 100:11666-11671
16. Schmerr MJ, Jenny AL, Bulgin MS, Miller JM, Hamir AN, Cutlip RC, Goodwin KR: Use of capillary electrophoresis and luorescent labeled peptides to dtect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr A 1999; 853:207-214
17. Yang W-C, Yeung ES, Schmerr MJ: Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorexcence detection and cyclodextrin-aided separation. Electrophoresis 2005; 26:1751-1759
18. Cervenáková L, Brown P, Soukharev S, Yakovleva O, Diringer H, Saenko EL, Drohan WN: Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis 2003; 24:853-859
19. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB: Eight prion strains have PrPsc molecules with different conformations. Nat Med 1998; 4:1157-1165
20. Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H: Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 2000; 97:5468-5473
21. Barletta JM, Edelman DC, Highsmith WE, Constantine NT: Detection of ultra-low levels of pathologic prion protein in scrapie-infected hamster brain homogenates using real-time immuno-PCR. J Virol Methods 2005; 127:154-164
22. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B: Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-474
23. Saborio GP, Permanne B, Soto C: Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-813
24. Soto C, Anderes L, Suardi S, Cardone F, Castilla J, Frossard MJ, Peano S, Saa P, Limido L, Carbonatto M, Ironside J, Torres J-M, Pocchiari M, Tagliavini F. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005; 579:638-642
25. Lane A, Stanley CJ, Dealer S, Wilson SM: Polymeric ligands with specificity for aggregated prion protein. Clin Chem 2003; 49:1774-1775
26. sc via conformationally responsive palindromic PrP peptides. Peptides 2005, in press